Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Breast Cancer Res Treat ; 188(3): 789-798, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33835293

RESUMEN

PURPOSE: Results from TAILOR-X suggest that up to 70% of hormone receptor-positive (HR+) node-negative (N0) ESBC patients (pts) may avoid chemotherapy (CT) with RS ≤ 25. We assess clinical and economic impacts of RS testing on treatment using real-world data. METHODS: From October 2011 to February 2019, a retrospective, cross-sectional observational study was conducted of HR+ N0 ESBC pts who had RS testing in Ireland. Pts were classified low risk (RS ≤ 25) and high risk (RS > 25). Clinical risk was calculated. Data were collected via electronic patient records. Cost data were supplied by the National Healthcare Pricing Regulatory Authority. RESULTS: 963 pts. Mean age is 56 years. Mean tumour size is 1.7 cm. 114 (11.8%), 635 (66%), 211 (22%), 3 (0.2%) pts had G1, G2, G3 and unknown G, respectively. 796 pts (82.8%) low RS, 159 (16.5%) high RS and 8 pts (0.7%) unknown RS. 263 pts (26%) were aged ≤ 50 at diagnosis; 117 (45%) had RS 0-15, 63 (24.5%) 16-20, 39 (15.3%) 21-25 and 40 (15.2%) RS 26-100. 4 pts (1.5%) had unknown RS. Post-RS testing, 602 pts (62.5%) had a change in CT decision; 593 changed to hormone therapy (HT) alone. In total, 262 pts received CT. Of pts receiving CT; 138 (53%) had RS > 25, 124 (47%) had RS ≤ 25. Of pts aged ≤ 50, 153 (58%) had high clinical risk, of whom 28 had RS 16-20. Assay use achieved a 62.5% change in treatment with 73% of pts avoiding CT. This resulted in savings of €4 million in treatment costs. Deducting assay costs, savings of €1.9 million were achieved. CONCLUSION: Over the 8 years of the study, a 62.5% reduction in CT use was achieved with savings of over €1,900,000.


Asunto(s)
Neoplasias de la Mama , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/epidemiología , Quimioterapia Adyuvante , Estudios Transversales , Femenino , Perfilación de la Expresión Génica , Humanos , Irlanda/epidemiología , Persona de Mediana Edad , Recurrencia Local de Neoplasia/genética , Receptores de Estrógenos/genética , Estudios Retrospectivos
2.
Clin Microbiol Infect ; 14(7): 719-22, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18558946

RESUMEN

Fifty-five Staphylococcus epidermidis isolates, classified as contaminants or causing device-related meningitis, from external ventricular drain (EVD) and non-EVD cerebrospinal fluid specimens were characterized. Thirty-three of 42 (78.6%) meningitis isolates were PCR-positive for ica and aap, known determinants of polysaccharide- and protein-mediated biofilm production, whereas five of 13 (38.5%) contaminants were ica- and aap-negative; 71.4% of meningitis isolates and 84.6% of contaminants produced biofilm. ica+aap+ meningitis isolates produced more biofilm than ica+aap- isolates (p 0.0020). ica+aap- isolates did not produce more biofilm than ica-aap+ isolates (p 0.4368). Apparently, ica and aap are associated with biofilm production in S. epidermidis device-related meningitis isolates.


Asunto(s)
Biopelículas , Derivaciones del Líquido Cefalorraquídeo/efectos adversos , Meningitis Bacterianas/microbiología , Infecciones Relacionadas con Prótesis/microbiología , Infecciones Estafilocócicas/microbiología , Staphylococcus epidermidis/genética , Staphylococcus epidermidis/fisiología , Adhesión Bacteriana , Técnicas de Tipificación Bacteriana , ADN Bacteriano/aislamiento & purificación , Contaminación de Equipos , Genes Bacterianos , Genotipo , Humanos , Meningitis Bacterianas/líquido cefalorraquídeo , Meningitis Bacterianas/etiología , Operón , Reacción en Cadena de la Polimerasa , Infecciones Relacionadas con Prótesis/líquido cefalorraquídeo , Infecciones Relacionadas con Prótesis/etiología , Infecciones Estafilocócicas/líquido cefalorraquídeo , Infecciones Estafilocócicas/etiología , Staphylococcus epidermidis/clasificación
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda